Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants
Public ClinicalTrials.gov record NCT00622505. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Bone Marker-directed Dosing of ZOMETA® (Zoledronic Acid) for the Prevention of Skeletal Complications in Patients With Advanced Multiple Myeloma.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study evaluated the effectiveness and safety of a dosing method for zoledronic acid in preventing skeletal complications in multiple myeloma participants who have been on an intravenous (IV) bisphosphonate for about one to two years.
Study identification
- NCT ID
- NCT00622505
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 121 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 7, 2007 (Actual)
- Primary completion
- Apr 3, 2012 (Actual)
- Completion
- Apr 3, 2012 (Actual)
- Last update posted
- May 26, 2021
2007 – 2012
United States locations
- U.S. sites
- 42
- U.S. states
- 22
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| TriValley Cancer Research and Treatment Center | Casa Grande | Arizona | 85222 | — |
| Wilshire Oncology Medical Group | La Verne | California | 91750 | — |
| Cedars Sinai Medical Center Outpatient Cancer Ctr. (4) | Los Angeles | California | 90048 | — |
| Palo Alto Medical Foundation Hematology/Oncology | Mountain View | California | 94040 | — |
| Oncology Care Medical Associates | San Gabriel | California | 91776 | — |
| Santa Clara Valley Health & Hospital System | San Jose | California | 95128 | — |
| University of Colorado U of Colorado Cancer Center | Aurora | Colorado | 80045 | — |
| Hematology Oncology PC | Stamford | Connecticut | 06902 | — |
| Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| Palm Beach Institute of Hematology Oncology | Boynton Beach | Florida | 33435 | — |
| Innovative Medical Research of South Florida Innovative Med Research | Miami Shores | Florida | 33138 | — |
| Cancer Centers of Florida PA Cancer Centers of Central FL | Ocoee | Florida | *see dep* | — |
| Integrated Community Oncology Network Florida Oncology Associates | Orange Park | Florida | 32073 | — |
| Cleveland Clinic Florida | Weston | Florida | 33331 | — |
| Loyola University Medical Center /Cardinal Bernardin Cancer Loyola Univ Med Ctr | Maywood | Illinois | 60153 | — |
| University of Maryland Greenebaum Cancer Center | Baltimore | Maryland | 21201 | — |
| Center for Cancer & Blood Disorders | Bethesda | Maryland | 20817 | — |
| Oncology - Hematology Associates, PA Oncology Hematology Assoc | Clinton | Maryland | 20735 | — |
| Dana Farber Cancer Institute Clinical Research Coordinator | Boston | Massachusetts | 02115 | — |
| Boston VA Healthcare Boston VA | Boston | Massachusetts | 02131 | — |
| Berkshire Hematology Oncology | Pittsfield | Massachusetts | 01201-8298 | — |
| N MS Hematology & Oncology | Tupelo | Mississippi | 38801 | — |
| Hematology & Oncology Consultants, PC Hematology & Oncology | Omaha | Nebraska | 68122-1799 | — |
| Somerset Hematology Oncology Associates Somerset Hema Oncol Assoc (2) | Somerset | New Jersey | 08873 | — |
| Cooper Cancer Center | Voorhees Township | New Jersey | 08043 | — |
| Rochester General Hospital / Lipson Cancer Center Lipson Cancer Center | Rochester | New York | 14621 | — |
| University of Rochester MC / James P. Wilmot Cancer Center James P. Wilmot Cancer Center | Rochester | New York | 14642 | — |
| SUNY - Upstate Medical University Div. of Hematology-Oncology | Syracuse | New York | 13210 | — |
| Carolina Oncology Specialists, PC | Hickory | North Carolina | 28602 | — |
| Regional Hematology-Oncology Associates PC | Langhorne | Pennsylvania | 19047 | — |
| Temple University Temple University | Philadelphia | Pennsylvania | 19140 | — |
| Medical Associates, PA | Charleston | South Carolina | 29403 | — |
| Low Country Hematology Oncology Dept of Lowcountry Hem/Onc | Mt. Pleasant | South Carolina | 29464 | — |
| Lexington Oncology Associates | West Columbia | South Carolina | 29169 | — |
| Avera Research Institute | Sioux Falls | South Dakota | 57105 | — |
| Blood and Cancer Center of East Texas | Tyler | Texas | 75701 | — |
| East Texas Medical Center Cancer Institute | Tyler | Texas | 75701 | — |
| Northern Utah Cancer Associates Dept.ofNorthernUtahAssoc. | Ogden | Utah | 84403-3105 | — |
| Central Utah Clinic Central Utah Clinic (8) | Provo | Utah | 84604 | — |
| Peninsula Cancer Institute | Newport News | Virginia | 23601 | — |
| Swedish Cancer Institute | Seattle | Washington | 98104 | — |
| West Virginia University Health Research Center Clinical Trial Research Unit | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00622505, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 26, 2021 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00622505 live on ClinicalTrials.gov.